Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1
Journal of Clinical Oncology · 10.07.2024 · 42 (20) · e44-e59
DOI: 10.1200/jco.24.00762 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.07.2024. Verfasst von Dwight H Owen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ohio State University, Columbus, OH. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ohio State University, Columbus, OH.
- American Society of Clinical Oncology, Alexandria, VA.
- The ROS1ders, Seattle, WA.
- Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- University of California, San Francisco, CA.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Dwight H Owen, Nofisat Ismaila, Janet Freeman-Daily, Navneet Singh, Ana I Velazquez, Natasha B Leighl
Zitieren
APA
Owen, D. H., Ismaila, N., Freeman-Daily, J., Roof, L., Singh, N., Velazquez, A. I., & Leighl, N. B. (2024). Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1. Journal of Clinical Oncology, 42(20), e44-e59. https://doi.org/10.1200/jco.24.00762
Vancouver
Owen DH, Ismaila N, Freeman-Daily J, Roof L, Singh N, Velazquez AI, et al. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1. Journal of Clinical Oncology. 2024;42(20):e44-e59. doi:10.1200/jco.24.00762
BibTeX
@article{Owen2024,
author = {Owen, Dwight H and Ismaila, Nofisat and Freeman-Daily, Janet and Roof, Logan and Singh, Navneet and Velazquez, Ana I and Leighl, Natasha B},
title = {Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {20},
pages = {e44--e59},
doi = {10.1200/jco.24.00762}
}
EUVIMED